Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
Clinical trial NCT04754945 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04754945
- Sponsor
- Emory University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2027-05-06
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.